Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin for paroxysmal atrial fibrillation recurrence after CABG
NCT01842529Phase 2Completed
- Sponsor
- E. Meshalkin National Medical Research Centre
- Start
- Sep 2012
- Primary completion
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of botulinum toxin type A in Atrial fibrillation (AFib), sponsored by E. Meshalkin National Medical Research Centre. Started Sep 2012; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01842529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01842529.